Body Mass and Glucocorticoid Response in Asthma
Overview
Affiliations
Rationale: Obesity may alter glucocorticoid response in asthma.
Objectives: To evaluate the relationship between body mass index (BMI, kg/m(2)) and glucocorticoid response in subjects with and without asthma.
Methods: Nonsmoking adult subjects underwent characterization of lung function, BMI, and spirometric response to prednisone. Dexamethasone (DEX, 10(-6) M)-induced mitogen-activated protein kinase phosphatase-1 (MKP-1) and baseline tumor necrosis factor (TNF)-alpha expression were evaluated by polymerase chain reaction in peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage cells. The relationship between BMI and expression of MKP-1 and TNF-alpha was analyzed.
Measurements And Main Results: A total of 45 nonsmoking adults, 33 with asthma (mean [SD] FEV(1)% of 70.7 [9.8]%) and 12 without asthma were enrolled. DEX-induced PBMC MKP-1 expression was reduced in overweight/obese versus lean patients with asthma, with mean (+/- SEM) fold-induction of 3.11 (+/-0.46) versus 5.27 (+/-0.66), respectively (P = 0.01). In patients with asthma, regression analysis revealed a -0.16 (+/-0.08)-fold decrease in DEX-induced MKP-1 per unit BMI increase (P = 0.04). PBMC TNF-alpha expression increased as BMI increased in subjects with asthma, with a 0.27 unit increase in log (TNF-alpha [ng/ml]) per unit BMI increase (P = 0.01). The ratio of PBMC log (TNF-alpha):DEX-induced MKP-1 also increased as BMI increased in patients with asthma (+0.09 +/- 0.02; P = 0.004). In bronchoalveolar lavage cells, DEX-induced MKP-1 expression was also reduced in overweight/obese versus lean patients with asthma (1.36 +/- 0.09-fold vs. 1.76 +/- 0.15-fold induction; P = 0.05). Similar findings were not observed in control subjects without asthma.
Conclusions: Elevated BMI is associated with blunted in vitro response to dexamethasone in overweight and obese patients with asthma.
Intramuscular methylprednisolone in hand osteoarthritis: a retrospective cohort study.
Hartog M, van Berkel J, van den Bemt B, van den Ende C, Popa C Rheumatol Adv Pract. 2024; 8(4):rkae136.
PMID: 39588297 PMC: 11588207. DOI: 10.1093/rap/rkae136.
Ingram J, McQuade V, Weiss J, Womble J, Ihrie M, Zhao K J Allergy Clin Immunol. 2024; 155(3):819-833.e10.
PMID: 39581293 PMC: 11875949. DOI: 10.1016/j.jaci.2024.10.039.
Association of Obesity and Severe Asthma in Adults.
Olejnik A, Kuznar-Kaminska B J Clin Med. 2024; 13(12).
PMID: 38930006 PMC: 11204497. DOI: 10.3390/jcm13123474.
Quarato C, Tondo P, Lacedonia D, Soccio P, Fuso P, Sabato E J Clin Med. 2024; 13(1).
PMID: 38202298 PMC: 10780210. DOI: 10.3390/jcm13010291.
Pathak M, Patowary P, Chattopadhyay P, Barbhuiyan P, Islam J, Gogoi J Endocr Metab Immune Disord Drug Targets. 2023; 24(9):1053-1068.
PMID: 37957906 DOI: 10.2174/0118715303256440231028072049.